Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Moderate Hypofractionated Boost to the Prostate With Pelvic RT in High Risk Prostate Cancer

NCT05313815 is registered in ClinicalTrials.gov with University Health Network, Toronto as lead sponsor.

NCT NCT05313815
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05313815 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Moderate Hypofractionated Boost to the Prostate With Pelvic RT in High Risk Prostate Cancer
Lead sponsor
University Health Network, Toronto
Phase
Not applicable
Overall status
Recruiting
Start date
July 18, 2022
Completion date
April 30, 2030
Enrollment
100 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

prostate cancer